Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Combination of beta-glucosylceramide and polyethoxylated castor oil and other adjuvants for controling blood sugar levels, immunoprotection and hepatoprotection

Inactive Publication Date: 2017-02-09
NATURAL SHIELD ISRAEL 2016 LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The invention is a combined composition that can be used to control blood sugar levels, treat immune-related disorders, treat liver damage, and prevent or delay the onset of toxic effects of drugs. The composition includes ingredients such as beta-glycolipids, polyethoxylated castor oil, and adjuvants like polyethylene glycol and beta-cyclo dextrin. The technical effect of the invention is to provide a more effective treatment for these medical conditions while minimizing the risk of drug toxicity.

Problems solved by technology

Intake of alcohol causes an initial surge in blood sugar, and later tends to cause hypoglycemia.
Consequences of chronic alcohol consumption are numerous, apart from risks of injuries sustained in car accidents and liver cirrhosis, there are also risks of anemia, cardiovascular disease, cancer and distinct neurologic and psychiatric disorders.
Sugar enriched foods, particularly soft drinks, and alcohol are considered among major health hazards produced by a modern way of living.
According to the American Heart Association, soft drinks and other sugar-sweetened beverages (SSBs) are the primary source of added sugars in Americans' diets; their increased consumption has been associated with rising obesity rates.
There is however apparent shortage of candidate food additives, natural or synthetic, having potential to counter-balance the negative effects of both, excess sugar and alcohol.
As previously mentioned, excessive alcohol consumption has immediate effects on many harmful health conditions, such as in increasing risk of injuries, violence, risky sexual behavior and unprotected sex, miscarriage and stillbirth among pregnant women.
Over time, excessive alcohol use can lead to the development of chronic diseases, including liver disease, alcoholic hepatitis and cirrhosis, the latter are among the leading causes of deaths in the US.
Several alterations in the metabolic state of the liver and other organs occur in response to the presence of alcohol (ethanol) in the body and can result in low blood sugar levels (hypoglycemia) [6].
Alcohol-induced hypoglycemia generally occurs after prolonged alcohol consumption coupled with poor nutritional intake, which not only decreases glucose production but also exhaust the reserves of glucose stored in the liver in the form of glycogen, thereby leading to hypoglycemia.
Its development is associated with an excess mortality both in relation to the presence of liver disease and to other complications of alcohol abuse.
Survival is significantly reduced in women and in the elderly and is adversely affected by the presence of severe liver injury, evolution to cirrhosis and continued drinking Two-thirds of patients with alcoholic cirrhosis present with decompensated disease; 15% will develop hepatocellular carcinoma.
Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming a worldwide public health problem.
Thus, the number of individuals at risk for end-stage liver disease and development of primary liver cancer and those potentially eligible for liver transplant is large.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Combination of beta-glucosylceramide and polyethoxylated castor oil and other adjuvants for controling blood sugar levels, immunoprotection and hepatoprotection
  • Combination of beta-glucosylceramide and polyethoxylated castor oil and other adjuvants for controling blood sugar levels, immunoprotection and hepatoprotection
  • Combination of beta-glucosylceramide and polyethoxylated castor oil and other adjuvants for controling blood sugar levels, immunoprotection and hepatoprotection

Examples

Experimental program
Comparison scheme
Effect test

example 1

GC and CE Add-On to SSBs Attenuate Increase of Serum Sugar Levels

[0373]To evaluate the ability of GC to control blood sugar levels during consumption of a high glucose beverage, the inventors examined the effect of GC alone and of GC with CE combination, on mice consuming various high sugar soft drinks. Table 1 shows the experimental groups of mice, including group A receiving orally Coca Cola +GC with CE (350 μl / mouse by gavage) and group B receiving Coca Cola (300 μl / mouse by gavage), using experimental procedures detailed above. Glucose levels were measured at 0, 15, and 30 min after Coca Cola administration.

TABLE 1The effect of GC + C:E on blood sugar levelsafter consumption of Coca ColaGroupTreatmentAUC 30 minutesACoca Cola + GC4381.25 ± 320N = 6BCoca Cola alone  4785 ± 208N = 6

[0374]The data in Table 1 and illustration thereof in FIG. 1 clearly show that add-on of the GC+C:E combination to Coca Cola attenuate the elevation in blood sugar levels occurring at 30 min after consum...

example 2

GC and CE Add-on to Orange Flavored Soda Prevents Increase of Sugar Levels in the Serum

[0377]The inventors further examined the effect of the GC+C:E combination on additional soft drinks. Table 3 shows the experimental groups of mice, including group A receiving orally Soda Stream supplemented with GC with C:E (350 μl / mouse by gavage) and group B receiving—Soda Stream alone (300 μl / mouse by gavage). Glucose levels were measured at 0, 15, and 30 and 60 min after Soda Stream administration.

TABLE 3The effect of GC + C:E on blood sugar levelsafter consumption of Soda StreamGroupTreatmentAUC 30 minutesAUC 60 minutesASoda Stream + GC with3406 ± 4407073.75 ± 675N = 6C:EBSoda Stream4121 ± 2938176.25 ± 364N = 6

[0378]FIGS. 3A and 3B illustrate that add-on of the GC+C:E combination to Soda Stream prevents the elevation of blood sugar levels accompanying consumption of SSBs (p=0.01 between groups for both, AUC 30 min. and AUC 60 min.). As shown in FIG. 3B, the effect persists after 60 min.

[0379...

example 3

Combination of GC with CE Add-on to SSBs Exerts a Synergistic Effect in Attenuating the Increase in Serum Sugar Levels

[0381]The inventors further characterized the ameliorating effect of the GC−C:E combination on the increase in blood sugar caused by SSBs Table 5 shows the experimental groups of mice, including group A receiving Coca Cola, group B—GC in C:E (Cremophor: Ethanol in 1:1 ratio), group C—Coca Cola with GC in ethanol, group D—Coca cola with C:E and Group E—Coca Cola with ethanol. The glucose blood levels of animals of the different groups were assayed in a glucose tolerance test (GTT).

TABLE 5The effect of GC + C:E on blood sugar levelsafter consumption of Coca ColaGroupTreatmentACoca ColaN = 6BCoca Cola + GC in C:EN = 6CCoca Cola + GC in EthanolN = 6DCoca Cola + C:EN = 6ECoca Cola + EthanolN = 6

[0382]FIGS. 5A-5D show the effect of GC+C:E and C:E on GTT. More specifically, FIG. 5A shows that GC+C:E improve GTT as compared to controls. FIG. 5B shows AUC at 30 minutes whereb...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Compositionaaaaaaaaaa
Electrical resistanceaaaaaaaaaa
Therapeuticaaaaaaaaaa
Login to View More

Abstract

The disclosure relates to compositions and methods for adding beta glucosylceramide and / or Cremophor EL (CE), or an adjuvant selected from polyethylene glycol and beta cyclo dextrin or any type of beta or alpha glucosylceramide with / without CE, or CE alone, to drinks or foods to serve as liver protectors, sugar protectors, and anti inflammatory protectors.

Description

FIELD OF INVENTION[0001]The present invention relates to the field of food supplements and therapeutic compositions. More particularly, the invention relates to combined therapeutic compositions and food supplements comprising GC and polyethoxylated castor oil (e.g. Cremophore EL) and optionally other adjutants such as polyethylene glycol or beta cyclo dextrin for controlling blood sugar levels and prevention of symptoms of pathological conditions related thereto.BACKGROUND REFERENCES[0002]1. Ludwig D S, et al. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. The Lancet, Volume 357, Issue 9255, pages 505-508 (2001).[0003]2. Schulze M B, et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA, Volume 292, Issue 8, pages 927-934 (2004).[0004]3. Dhingra R et al. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7028A23L2/60A23L33/10A61K36/47A61K45/06
CPCA61K31/7028A61K36/47A23V2002/00A23L33/10A23L2/60A61K45/06A23L2/52A23L5/00A23L29/30A23L33/12A23L33/125A61K31/70A61P1/16A61P1/18A61P3/10A61P37/00C12C5/02C12G3/00C12G2200/21A61K2300/00
Inventor ILAN, YARON
Owner NATURAL SHIELD ISRAEL 2016 LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com